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INTRODUCTION
The organic anion transporter (OAT) family mediates the body disposition of a diverse array of environmental toxins, and clinically important drugs, including anti-HIV therapeutics, anti-tumor drugs, antibiotics, anti-hypertensives, and anti-inflammatories (Ahn and Nigam, 2009; Dantzler and Wright, 2003; Srimaroeng et al., 2008; VanWert et al., 2010; You, 2002) . Therefore, understanding the regulation of these transporters has profound clinical significance.
Ten OATs (OAT1-10) have been cloned, and their expressions identified in distinct tissues and cell membranes. In the kidney, OAT1 and OAT3 utilize a tertiary transport mechanism to move organic anions across the basolateral membrane into the proximal tubule cells for subsequent exit across the apical membrane into the urine for elimination. Through this tertiary transport mechanism, Na + /K + -ATPase maintains an inwardly directed (blood-to-cell) Na + gradient. The Na + gradient then drives a sodium dicarboxylate cotransporter, sustaining an outwardly directed dicarboxylate gradient that is utilized by a dicarboxylate/organic anion exchanger, namely OAT, to move the organic anion substrate into the cell. This cascade of events indirectly links organic anion transport to metabolic energy and the Na + gradient, allowing the entry of a negatively charged substrate against both its chemical concentration gradient and the electrical potential of the cell (Ahn and Nigam, 2009; Dantzler and Wright, 2003; Srimaroeng et al., 2008; VanWert et al., 2010; You, 2002) .
All of the cloned OATs share several common structural features including 12 transmembrane domains flanked by intracellular amino-and carboxyl termini; multiple glycosylation sites localized in the first extracellular loop and multiple potential phosphorylation sites. Investigation from our laboratory on the structure-function relationship of OATs revealed that glycosylation is necessary for the targeting of these transporters to the plasma membrane (Tanaka et al., 2004) .
The amount of OATs at the cell surface is critical for their drug transport activity. We previously showed that members of OAT family constitutively internalize from and recycle back to cell surface, and that inhibition of OAT activity by acute activation of PKC results from an This article has not been copyedited and formatted. The final version may differ from this version. accelerated internalization of these transporters from cell surface to intracellular compartments
Preparation of rat kidney slices -Male Sprague Dawley rats were euthanized by CO 2 inhalation, and the kidneys were immediately placed into freshly oxygenated ice-cold saline. Tissue slices (<0.5 mm; 5-10 mg wet weight) were cut with a Stadie-Riggs microtome and maintained in ice-cold modified Cross and Taggart saline (95 mM NaCl, 80 mM mannitol, 5 mM KCl, 0.74 mM CaCl 2 , and 9.5 mM Na 2 PO 4 , pH 7.4) for ubiquitination studies.
Cell Surface Biotinylation -Cell surface expression level of OAT1 was examined using the membrane-impermeable biotinylation reagent, NHS-SS-biotin. Cells were plated in six-well plates.
Each well of cells was incubated with 1 ml of NHS-SS-biotin (0.5 mg/ml in PBS) in two successive 20 min incubations on ice with very gentle shaking. The reagent was freshly prepared each time.
After biotinylation, each well was briefly rinsed with 3 ml of PBS/CM containing 100 mM glycine then incubated with the same solution for 30 min on ice, to ensure complete quenching of the unreacted NHS-SS-biotin. The cells were then lysed on ice for 1 h in 400 l of lysis buffer (10 mM Tris, 150 mM NaCl, 1 mM EDTA, 0.1 % SDS, 1% Triton-X 100 with 1/100 protease inhibitor cocktail). The cell lysates were cleared by centrifugation at 16,000 x g at 4 o C. 50 l of streptavidin-agarose beads were then added to the supernatant to isolate cell membrane proteins. OAT1 was detected in the pool of surface proteins by immunoblotting using an anti-myc antibody 9E10.
To determine ubiquitinated OAT1 in the biotinylated protein fraction, cell surface proteins were biotinylated. OAT1 was immunoprecipitated with anti-myc antibody. Immunoprecipitated proteins were eluted from the beads with 1% SDS (37 ˚C, 15 min). Next, SDS was diluted to 0.1%, and the eluted OAT1 proteins were incubated with streptavidin-agarose beads, followed by immunoblotting using anti-ubiquitin antibody P4D1 or anti-myc antibody.
Internalization Assay -We followed the procedure previously established in our lab (Zhang et al., 2008) . OAT1-expressing cells underwent biotinylation with 0.5 mg/ml sulfo-NHS-SS-biotin at 4 °C.
This article has not been copyedited and formatted. The final version may differ from this version. Purification of ubiquitinated OAT1 by sequential immunoprecipitation -Six 10-cm-diameter dishes of COS-7 cells expressing OAT1 were treated with 1µM PMA for 30 min at 37 °C. Treated cells were solubilized with lysis buffer I with 3% proteinase inhibitor cocktail and 40 mM NEM. Total cell lysate was pre-cleared with protein G-agarose for 2 h at 4°C, followed by immunoprecipitation with anti-myc antibody that was cross-linked to protein G beads with dimethyl pimelimidate (Pierce).
After extensive wash with lysis buffer I containing 500 mM NaCl, the immunoprecipitated proteins were eluted with 1% SDS and immunoprecipitated again with anti-ubiquitin antibody FK2 that was cross-linked to protein G beads with dimethyl pimelimidate. After the second immunoprecipitation, 10% of precipitated proteins were analyzed by immunoblotting with anti-ubiquitin antibody P4D1 or anti-myc antibody and 90% by Coomassie blue staining. antibody, it was shown that these short-term treatments did not produce any major change in the amount of OAT1 (Fig. 1b) . The PMA-induced OAT1 ubiquitination was blocked by staurosporin, a general PKC inhibitor ( Fig. 2a ) without affecting the total amount of OAT1 ( Fig. 2b ), demonstrating the specific involvement of PKC in OAT1 ubiquitination. The ubiquitin-immunoreactive signal displayed a smeary band centered ~140 kDa, ~60 kDa larger than the size of OAT1 (~80 kDa).
Protein identification by LC-MS/MS
Given that each ubiquitin molecule is ~ 8 kDa, OAT1 most likely is either multiubiquitinated or polyubiquitinated. A similar experiment was then performed with rat kidney slices (Fig. 3) . Upon PMA treatment, dramatic increase of OAT1 ubiquitination was detected. Again, such ubiquitination was blocked by PKC inhibitor staurosporin (Fig. 3a) . These results suggest that OAT1, regardless of species origin, undergoes PKC-regulated ubiquitination both in cultured cells and in rat kidney tissue.
PKC-induced ubiquitination of OAT1 by ectopically expressed ubiquitin -OAT1-expressing cells
were transiently transfected with HA-tagged ubiquitin. Transfected cells were treated with PMA in the presence and the absence of PKC inhibitor staurosporin. OAT1 was then immunoprecipitated, followed by immunoblotting with anti-HA antibody (to detect HA-tagged ubiquitin). HA immunoreactivity was dramatically increased in the samples treated with PMA, and was significantly This article has not been copyedited and formatted. The final version may differ from this version. decreased in the presence of staurosporin ( Fig. 4a) , indicating that the conjugation of HA-ubiquitin to OAT1 is PKC-dependent.
OAT1 ubiquitination at the cell surface -To determine whether OAT1 ubiquitination occurs at the cell surface, we developed a two-step procedure to ensure that only cell surface OAT1 ubiquitination was detected (Fig. 5a ). Briefly, cell surface proteins were labeled with or without membrane impermeable reagent NHS-SS-biotin. Labeled cells were lysed. OAT1 was then immunoprecipitated, with subsequent streptavidin pull-down to isolate cell surface OAT1.
Immunoblotting of this streptavidin pull-down with anti-ubiquitin antibody showed no signal for ubiquitin in cells not labeled with biotin. However in cells labeled with biotin, ubiquitin signal dramatically increased in the presence of PMA. This result demonstrated that the two-step procedure detected only cell surface OAT1 ubiquitination. Using this procedure, we next examined the effect of a dominant negative mutant of dynamin-2 (Dyn-2m) on OAT1 ubiquitination. We previously demonstrated that OAT1 internalization occurred partly through a dynamin-and clathrindependent pathway and that such internalization was blocked in cells transfected with a Dyn-2m.
As a result, OAT1 accumulated at the cell surface (Zhang et al., 2008 ). In the current experiment, we transfected OAT1-expressing cells with Dyn-2m (or empty vector as control). Transfected cells were treated with PMA for 30 min and cell surface proteins were biotinylated, followed by the same procedure shown in Fig. 5a for the detection of cell surface OAT1 ubiquitination. Our results showed that ubiquitinated OAT1 was significantly elevated in cells transfected with Dyn-2m (Figs.
5b & 5c), a maneuver that blocked OAT1 internalization. These data indicate that OAT1 is preferentially ubiquitinated when present at the cell surface and that ubiquitination of OAT1 precedes its internalization.
Identification of ubiquitination linkage of OAT1 -As mentioned above, different types of ubiquitination (mono-versus polyubiquitination via different types of linkages) have different
This article has not been copyedited and formatted. The final version may differ from this version. OAT1 was immunoprecipitated, followed by a second immunoprecipitation using ubiquitin-specific antibody to purify ubiquitinated OAT1 (normal IgG as negative control). The ubiquitinated OAT1 was then separated on SDS-PAGE, followed by Coomassie blue-staining. A Coomassie blue-stained broad band centered ~140 kDa was dissected for mass spectrometric analysis, and a sufficient amount of information regarding the peptides which originated from ubiquitin sequences was obtained. Among various peptides identified from ubiquitin, which cover all its seven lysine residues, only K48-linked ubiquitin was detected (Table 1) . These results indicate that OAT1 is ubiquitinated mainly through K48-linked polyubiquitin chains.
The role of K48-linked polyubiquitin chains in PKC-regulated OAT1 ubiquitination -To explore the role of K48-linked polyubiquitin chains in PKC-regulated OAT1 ubiquitination, we employed four HA-tagged-ubiquitin constructs: wild type ubiquitin Ub, mutant ubiquitin UbΔG (Kolodziejski et al., 2002) , which has the C-terminal Gly residue deleted and therefore prevents the conjugation of ubiquitin to OAT1, mutant ubiquitin Ub-K48R (Li et al., 2007) , which has the invariant Lys in position 48 mutated to Arg and prevents the formation of K48-linked polyubiquitin chains, and mutant ubiquitin Ub-K63R (Li et al., 2007) , which has the invariant Lys in position 63 mutated to Arg and prevents the formation of K63-linked polyubiquitin chains. cDNAs encoding these ubiquitin constructs were transfected into OAT1-expressing cells. Transfected cells were treated with or without PMA. OAT1 was then immunoprecipitated, followed by immunoblotting with anti-HA antibody. Our results (Fig. 6) showed that PMA treatment resulted in a strong HA-immuno-reactive signal in both Ub-and Ub-K63R-transfected cells, suggesting that significant amount of Ub and Ub-K63R were incorporated into OAT1. In contrast, the same treatment resulted in almost no detection of HA-immuno-reactive signal in both UbΔG-and Ub-K48R-transfected cells. There was no major
This article has not been copyedited and formatted. The final version may differ from this version. (Zhang et al., 2008) . To explore the role of K48-linked polyubiquitin chains of OAT1 in this process, we examined PKC-regulated OAT1 surface expression and internalization in cells transfected with Ub-K48R. As shown in Fig. 7 , PMA treatment resulted in a significant decrease in OAT1 surface expression in control cells, whereas such PMA effect was substantially reversed in Ub-K48R-transfected cells. Similarly, PMA treatment resulted in a significant increase in OAT1 internalization in control cells, whereas such PMA effect was substantially reversed in Ub-K48R-transfected cells (Fig. 8) . These data indicate that K48-linked polyubiquitin chains of OAT1 are essential for PKC-regulated OAT1 surface expression and internalization.
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DISCUSSION
The organic anion transporter (OAT) family mediates the body disposition of a diverse array of environmental toxins, and clinically important drugs. Therefore, understanding the regulation of these transporters has profound clinical significance. Short-term (acute) regulation of OAT activity is particularly important when body has to deal with rapidly changing amounts of substances as a consequence of variable intake of drug, fluid, and meal as well as metabolic activity.
The amount of OATs at the cell surface is critical for their drug transport activity. We previously established that OAT1 undergoes constitutive internalization from and recycling back to cell surface and that acute activation of PKC inhibits OAT1 activity by reducing OAT1 cell surface expression through accelerating its internalization from cell surface to intracellular compartments without affecting the recycling and the total expression of the transporter (Zhang et al., 2008) . Due to such characteristic, PKC inhibition of OAT1 activity is usually moderate (30-50%), because there is always a certain amount of hOAT1 at the cell surface resulting from the recycling, even with the maximum stimulation of PKC. In vivo, regulation at such a moderate scale may play an important role in providing quick and efficient fine tuning in the body response to environmental changes.
However, the mechanisms underlying PKC-regulated OAT1 trafficking are largely unknown. In the current study, we provide the first demonstration that a topology-specific polyubiquitination of OAT1 plays an essential role in this process.
We first examined OAT1 ubiquitination in COS-7 cells stably expressing this transporter. endogenous OATs. Therefore, expression of OAT1 in COS-7 cells will allow us to dissect the transport characteristics of OAT1 in a relevant mammalian system without the possibly confounding effects of other organic anion transporters. (iii) They possess endogenous PKC and PKA signaling pathways and provide a good experimental model system for studying the regulatory mechanisms underlying many transport processes (Cobb et al., 2002; Kazanietz et al., 2001 ). (iv) The transport characteristics of OAT1 in COS-7 cells were in a good agreement with that observed in other systems (Miller, 1998; Shuprisha et al., 2000; Zhang et al., 2008) . Using these cells, we obtained new data showing that under basal condition, OAT1 was not significantly ubiquitinated. However, acute activation of PKC by PMA induced a time-dependent increase in OAT1 ubiquitination ( Fig. 1) and that PMA-induced ubiquitination was blocked by PKC inhibitor staurosporin (Fig. 2) , confirming that this PMA effect was indeed PKC-dependent. The result was further confirmed with naturally occurring OAT1 from rat kidney (Fig. 3) , providing the physiological relevance for our study.
We previously demonstrated that OAT1 internalizes partly through a dynamin-and clathrindependent pathway and that such internalization was blocked in cells transfected with a dominant negative mutant of dynamin-2. As a result, OAT1 accumulated at the cell surface (You et al., 2000) .
In the current study, we showed ( OAT1 ubiquitination, we performed mass spectrometric analysis, one of the most powerful approaches to identify post-translational modifications of numerous proteins. For such purpose, we developed sequential immunoprecipitation procedures ensuring that the high purity of ubiquitinated OAT1 was used. The mass spectrometric results indeed confirmed that ubiquitin and OAT1 were the two predominant proteins detected in our sample, providing evidence that ubiquitin was conjugated to OAT1 rather than to an OAT1-associated protein. Furthermore, our mass spectrometric analysis identified several peptide fragments from ubiquitin protein, which covered all its seven lysine residues. Among these fragments, only K48-linked ubiquitin was detected (Table 1) .
These results indicate that OAT1 is ubiquitinated mainly through K48-linked polyubiquitin chains.
The mass spectrometric data that OAT1 was ubiquitinated mainly through K48-linked polyubiquitin chains was independently confirmed through the use of a series of ubiquitin mutants (Fig. 6) . The mutant Ub-K63R, which is defective of forming K63-linked polyubiquitin chains, incorporated into OAT1 as efficiently as that of wild type ubiquitin, whereas mutant Ub-K48R, which is defective of forming K48-linked polyubiquitin chains had the minimum incorporation into OAT1.
The strong evidence on the importance of K48-linked polyubiquitination for OAT1 trafficking came from our studies using dominant negative ubiquitin mutant Ub-K48R. Interfering with K48-linked polyubiquitination impeded PKC-induced down-regulation of OAT1 surface expression (Fig. 7) and PKC-accelerated OAT1 internalization (Fig. 8) .
It is important to note, our entire study investigated the role of ubiquitination in short-term without affecting their degradation (Mukhopadhyay et al., 2007) . It would be really interesting to explore, in the future, whether long-term treatment with PMA (2-8 hrs) would affect OAT1 degradation.
In conclusion, ubiquitination has been shown to regulate internalization, post-internalization sorting and degradation of other membrane proteins. Our current investigation focuses on the first step: the internalization step. The major findings from our studies are (Fig. 9 ): 1) activation of PKC promotes OAT1 ubiquitination both in vitro and ex vivo. 2) OAT1 ubiquitination mainly occurs at the cell surface through K48-linked polyubiquitin chains. 3) K48-linked polyubiquitination plays an essential role in PKC-regulated OAT1 trafficking.
To the best of our knowledge, this report is the first mechanistic study to demonstrate a topology-specific role of ubiquitination in the regulation of any drug transporters. What would be the physiological implication of our studies? Abnormal OAT1 trafficking may contribute to the impaired drug elimination in bilateral ureteral obstruction (BUO). BUO is a serious and common clinical condition, and an important cause of acute renal failure (Seldin and Giebisch, 2000; Villar et al., 2005) . It is shown (Villar et al., 2005) that in BUO rats, elimination of drugs was impaired partly due to a redistribution of OAT1 from cell surface to intracellular compartment. In BUO, angiotensin II has elevated level of expression (Klahr, 1998; Klahr and Morrissey, 2002; Seldin and Giebisch, 2000) . We previously reported that angiotensin II inhibits OAT1 activity through activation of PKC in cultured cells (Li et al., 2009 ). Therefore, the high level of angiotensin II in BUO rats may inhibit OAT1 activity through PKC-regulated OAT1 ubiquitination and trafficking. Our current studies may provide important insight into the molecular, cellular, and clinical bases underlying BUO.
Finally, while the limited coverage of OAT1-derived peptides did not allow us to identify the ubiquitin-accepting lysine residues on OAT1 using mass spectrometry in this study, when the current manuscript was being reviewed, we resorted to a different approach -site-directed mutagenesis, and succeeded in identification of three lysine residues on OAT1, which serve as ubiquitin acceptors (a separate manuscript submitted). Our work paves the way for investigation This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. a An asterisk Denotes Gly-Gly modification of the -amino group of the lysine side chain.
